146 related articles for article (PubMed ID: 22526320)
21. Characterisation of a unique ceftazidime-hydrolysing beta-lactamase, TEM-E2.
Payne DJ; Marriott MS; Amyes SG
J Med Microbiol; 1990 Jun; 32(2):131-4. PubMed ID: 2192063
[TBL] [Abstract][Full Text] [Related]
22. Beta-lactamase stability of temocillin.
Edmondson RA; Reading C
Drugs; 1985; 29 Suppl 5():64-6. PubMed ID: 3875474
[TBL] [Abstract][Full Text] [Related]
23. Mutagenesis and structural analysis reveal the CTX-M β-lactamase active site is optimized for cephalosporin catalysis and drug resistance.
Lu S; Montoya M; Hu L; Neetu N; Sankaran B; Prasad BVV; Palzkill T
J Biol Chem; 2023 May; 299(5):104630. PubMed ID: 36963495
[TBL] [Abstract][Full Text] [Related]
24. Comparison of the in vitro and in vivo antibacterial activities of cefepime (BMY-28142) with ceftazidime, cefuzonam, cefotaxime and cefmenoxime.
Masuyoshi S; Hiraoka M; Inoue M; Tomatsu K; Hirano M; Mitsuhashi S
Drugs Exp Clin Res; 1989; 15(1):1-10. PubMed ID: 2663406
[TBL] [Abstract][Full Text] [Related]
25. Activity of cefepime, cefotaxime, ceftazidime, and aztreonam against extended-spectrum-producing isolates of Klebsiella pneumoniae and Escherichia coli from Chilean hospitals.
Zemelman C; Bello H; Domínguez M; González G; Mella S; Zemelman R
Diagn Microbiol Infect Dis; 2001; 40(1-2):41-3. PubMed ID: 11448562
[TBL] [Abstract][Full Text] [Related]
26. CTX-M-5, a novel cefotaxime-hydrolyzing beta-lactamase from an outbreak of Salmonella typhimurium in Latvia.
Bradford PA; Yang Y; Sahm D; Grope I; Gardovska D; Storch G
Antimicrob Agents Chemother; 1998 Aug; 42(8):1980-4. PubMed ID: 9687393
[TBL] [Abstract][Full Text] [Related]
27. Sequence of the gene encoding a plasmid-mediated cefotaxime-hydrolyzing class A beta-lactamase (CTX-M-4): involvement of serine 237 in cephalosporin hydrolysis.
Gazouli M; Tzelepi E; Sidorenko SV; Tzouvelekis LS
Antimicrob Agents Chemother; 1998 May; 42(5):1259-62. PubMed ID: 9593162
[TBL] [Abstract][Full Text] [Related]
28. Evaluation of MicroScan WalkAway and Vitek 2 for determination of the susceptibility of extended-spectrum β-lactamase-producing Escherichia coli and Klebsiella pneumoniae isolates to cefepime, cefotaxime and ceftazidime.
Jang W; Park YJ; Park KG; Yu J
J Antimicrob Chemother; 2013 Oct; 68(10):2282-5. PubMed ID: 23671215
[TBL] [Abstract][Full Text] [Related]
29. CTX-M-type extended-spectrum beta-lactamase that hydrolyzes ceftazidime through a single amino acid substitution in the omega loop.
Poirel L; Naas T; Le Thomas I; Karim A; Bingen E; Nordmann P
Antimicrob Agents Chemother; 2001 Dec; 45(12):3355-61. PubMed ID: 11709308
[TBL] [Abstract][Full Text] [Related]
30. PER-7, an extended-spectrum beta-lactamase with increased activity toward broad-spectrum cephalosporins in Acinetobacter baumannii.
Bonnin RA; Potron A; Poirel L; Lecuyer H; Neri R; Nordmann P
Antimicrob Agents Chemother; 2011 May; 55(5):2424-7. PubMed ID: 21383087
[TBL] [Abstract][Full Text] [Related]
31. Characterization of VIM-2, a carbapenem-hydrolyzing metallo-beta-lactamase and its plasmid- and integron-borne gene from a Pseudomonas aeruginosa clinical isolate in France.
Poirel L; Naas T; Nicolas D; Collet L; Bellais S; Cavallo JD; Nordmann P
Antimicrob Agents Chemother; 2000 Apr; 44(4):891-7. PubMed ID: 10722487
[TBL] [Abstract][Full Text] [Related]
32. Novel ambler class A carbapenem-hydrolyzing beta-lactamase from a Pseudomonas fluorescens isolate from the Seine River, Paris, France.
Girlich D; Poirel L; Nordmann P
Antimicrob Agents Chemother; 2010 Jan; 54(1):328-32. PubMed ID: 19901091
[TBL] [Abstract][Full Text] [Related]
33. Molecular and biochemical characterization of Ambler class A extended-spectrum beta-lactamase CGA-1 from Chryseobacterium gleum.
Bellais S; Naas T; Nordmann P
Antimicrob Agents Chemother; 2002 Apr; 46(4):966-70. PubMed ID: 11897576
[TBL] [Abstract][Full Text] [Related]
34. Emergence of a cefepime- and cefpirome-resistant Citrobacter freundii clinical isolate harbouring a novel chromosomally encoded AmpC beta-lactamase, CMY-37.
Ahmed AM; Shimamoto T
Int J Antimicrob Agents; 2008 Sep; 32(3):256-61. PubMed ID: 18619820
[TBL] [Abstract][Full Text] [Related]
35. Chromosomal beta-lactamase of Klebsiella oxytoca, a new class A enzyme that hydrolyzes broad-spectrum beta-lactam antibiotics.
Arakawa Y; Ohta M; Kido N; Mori M; Ito H; Komatsu T; Fujii Y; Kato N
Antimicrob Agents Chemother; 1989 Jan; 33(1):63-70. PubMed ID: 2653216
[TBL] [Abstract][Full Text] [Related]
36. Structural and Mechanistic Basis for Extended-Spectrum Drug-Resistance Mutations in Altering the Specificity of TEM, CTX-M, and KPC β-lactamases.
Palzkill T
Front Mol Biosci; 2018; 5():16. PubMed ID: 29527530
[TBL] [Abstract][Full Text] [Related]
37. Use of the cefepime-clavulanate ESBL Etest for detection of extended-spectrum beta-lactamases in AmpC co-producing bacteria.
Mohanty S; Gaind R; Ranjan R; Deb M
J Infect Dev Ctries; 2009 Nov; 4(1):24-9. PubMed ID: 20130375
[TBL] [Abstract][Full Text] [Related]
38. The spread of CTX-M-type extended-spectrum beta-lactamases.
Rossolini GM; D'Andrea MM; Mugnaioli C
Clin Microbiol Infect; 2008 Jan; 14 Suppl 1():33-41. PubMed ID: 18154526
[TBL] [Abstract][Full Text] [Related]
39. Characterization of an extended-spectrum class A β-lactamase from a novel enterobacterial species taxonomically related to Rahnella spp./Ewingella spp.
Lartigue MF; Nordmann P; Edelstein MV; Cuzon G; Brisse S; Poirel L
J Antimicrob Chemother; 2013 Aug; 68(8):1733-6. PubMed ID: 23580557
[TBL] [Abstract][Full Text] [Related]
40. A novel CTX-M beta-lactamase (CTX-M-8) in cefotaxime-resistant Enterobacteriaceae isolated in Brazil.
Bonnet R; Sampaio JL; Labia R; De Champs C; Sirot D; Chanal C; Sirot J
Antimicrob Agents Chemother; 2000 Jul; 44(7):1936-42. PubMed ID: 10858358
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
